# Brazil pharmaceutical regulation and digital prescriptions

> Live situation record from CLSTR: https://clstr.news/situations/brazil-pharmaceutical-regulation-and-digital-prescriptions
> Updated: 2026-09-30T17:56:00.000Z. Sources: 51. Developments: 2.

Brazil’s National Health Surveillance Agency (Anvisa) is managing regulatory oversight regarding pharmaceutical sales and digital prescription systems.

Anvisa has formally notified Mercado Livre to provide information concerning its plans to sell prescription medications online starting in October. The agency is investigating the company’s regulatory compliance, specifically its pharmacy authorization, sanitary licenses, and technical pharmacist identification, noting that current regulations do not automatically authorize marketplaces to intermediate pharmaceutical sales. Anvisa is seeking clarification on protocols for the storage, transport, and verification of medical prescriptions.

This development has impacted market dynamics, causing a decline in shares for major retail pharmacy chains, including Raia Drogasil and Pague Menos, and prompting requests for clarification from the Brazilian Association of Pharmacy and Drugstore Chains (Abrafarma). Mercado Livre has stated it is in dialogue with regulatory bodies and aims to integrate third-party pharmacies into its ecosystem, targeting 20 partners by the end of the year.

In parallel, Anvisa has implemented updates to the National Prescription Control System (SNCR) to facilitate electronic medical prescriptions. The system now enables the electronic issuance and monitoring of blue and yellow prescription notifications, which were previously restricted to paper. Digital oversight has also expanded to include antimicrobials and GLP-1 agonists. While paper prescriptions remain valid, a transition period is underway for white prescriptions; after October 30, any electronic white prescriptions must be integrated into the SNCR.

## Claims

- Anvisa formally notified Mercado Livre regarding its plan to sell prescription medications via its marketplace. (disputed by 8 sources)
- Mercado Livre stated it has not yet received any formal notification regarding the inquiry. (disputed by 4 sources)
- The new electronic functionalities do not make digital prescriptions mandatory. (corroborated by 7 sources)
- Blue and yellow prescription notifications can now be issued electronically. (corroborated by 7 sources)
- Electronic control is being extended to antimicrobials and GLP-1 agonists. (corroborated by 7 sources)
- The SNCR began operations in July 2024 to support sanitary surveillance. (corroborated by 7 sources)
- There is currently no regulatory provision authorizing marketplaces to act as intermediaries for the sale of medications. (corroborated by 7 sources)
- Anvisa requested data regarding Mercado Livre's regulatory compliance, including technical responsibility and storage rules. (corroborated by 7 sources)
- The Brazilian Association of Pharmacy and Drugstore Chains (Abrafarma) requested urgent clarification from Anvisa regarding the legality of the marketplace model. (corroborated by 3 sources)
- White prescriptions must be integrated into the SNCR if issued electronically starting October 30. (single source)
- Mercado Livre plans to include three third-party pharmacies on its platform in October, aiming for 20 by the end of the year. (single source)

## Timeline

### 2026-09-30: Anvisa implements new medical prescription rules and cosmetic regulations

Anvisa has introduced digital medical prescription controls via the SNCR system and implemented new regulations for artisanal cosmetics, while simultaneously banning several counterfeit and unauthorized health/

40 sources. https://clstr.news/cluster/anvisa-implements-electronic-medical-prescription-controls-in-brazil

### 2026-09-28: Mercado Livre notified by Anvisa over prescription drug sales

Anvisa has notified Mercado Livre to clarify the legality of its plan to sell prescription drugs via its marketplace, amid opposition from pharmacy associations and regulatory uncertainty.

14 sources. https://clstr.news/cluster/anvisa-issues-new-guidance-for-controlled-prescription-management

---
Cite as: Brazil pharmaceutical regulation and digital prescriptions. CLSTR, https://clstr.news/situations/brazil-pharmaceutical-regulation-and-digital-prescriptions